Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23: Results of a pilot study in the SIREN cohort

Publication date: Dec 09, 2024

Introduction The combination of patient illness and staff absence driven by seasonal viruses culminates in annual “winter pressures” on UK healthcare systems and has been exacerbated by COVID-19. In winter 2022/23 we ran a pilot study aiming to introduce multiplex testing to determine the incidence and burden of SARS-CoV-2, influenza and respiratory syncytial virus (RSV) in our cohort of UK healthcare workers (HCWs). Methods The pilot study was conducted from 28/11/2022-31/03/2023 within the SIREN prospective cohort study. Participants completed fortnightly questionnaires, capturing symptoms and sick leave, and multiplex PCR testing for SARS-CoV-2, influenza and RSV, regardless of symptoms. PCR-positivity rates by virus were calculated over time, and viruses were compared by symptoms and severity. Self-reported symptoms and associated sick leave were described. Sick leave rates were compared by vaccination status and demographics. Results 5,863 participants were included, 84.6% female, 70.3% >=45-years, and 33.4% were nurses. PCR-positivity peaked in early December for all three viruses (4.6 positives per 100 tests (95%CI 3.5, 5.7) SARS-CoV-2, 3.9 (95%CI 2.2, 5.6) influenza, 1.4 (95%CI 0.4, 2.4) RSV), declining to

PDF

Concepts Keywords
Conducting Cohort
Influenza Cov
Nurses Covid
Days
December
Influenza
Leave
Medrxiv
Participants
Preprint
Respiratory
Rsv
Sars
Sick
Winter

Semantics

Type Source Name
disease MESH COVID-19
disease MESH influenza
drug DRUGBANK Etoperidone
drug DRUGBANK Ranitidine
disease MESH Sore throat
disease MESH infections
disease MESH Emergency
disease IDO immunosuppression
disease MESH morbidities
disease MESH viral infections
disease MESH RSV infections
disease IDO symptom
disease MESH nosocomial infections
disease MESH asymptomatic infections
disease MESH respiratory infections
drug DRUGBANK Coenzyme M
disease MESH Delta infection
disease IDO infection
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH REinfection

Download Document

(Visited 1 times, 1 visits today)